Herbas VPB

Print
EN | LT
LT - USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS
EN - USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 15/113 (2010.01)
A61K 38/17 (2006.01)
A61P 41/00 (2006.01)
A61P 19/02 (2006.01)
European patent
(11) Number of the document 2238250
(13) Kind of document T
(96) European patent application number 08866608.6
Date of filing the European patent application 2008-12-22
(97) Date of publication of the European application 2010-10-13
(45) Date of publication and mention of the grant of the patent 2017-07-19
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2008/014020
Date 2008-12-22
PCT application publication
(87) Number WO 2009/085269
Date 2009-07-09
Priority applications
(30) Number Date Country code
8660 P 2007-12-21 US
Inventors
(72)
BECKER, David, L., GB
GREEN, Colin, R., NZ
DUFT, Bradford, J., US
Grantee
(73) Ocunexus Therapeutics, Inc., 12481 High Bluff Drive, Suite 150, San Diego CA 92130, US
Title
(54) USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS
  USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS
Last update date 2021-04-30